Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating ustekinumab induction and maintenance therapy for moderately to severely active ulcerative colitis has completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Colitis, Ulcerative, Inflammatory Bowel Diseases | Phase 3 | Status: COMPLETED | Results posted: 2019-12-23